Uneek Mehra

Uneek Mehra

Geen lopende functies

Vermogen: 11 110 $ op 30-06-2026

53 jaar
Health Technology
Consumer Services

Profiel

Uneek Mehra is currently Chief Financial Officer at Bridgebio Oncology Therapeutics, Inc. since 2025.
Former positions include Chief Financial Officer at Proteus Digital Health, Inc.; Chief Financial Officer at Bridgebio Oncology Therapeutics, Inc. from 2025 to 2026; Global Head-Portfolio Management at Novartis AG; Chief Financial & Business Officer at Myovant Sciences, Inc. and Myovant Sciences Ltd.; Chief Financial Officer & Treasurer at PACT Pharma, Inc.; and Chief Financial & Business Officer at 4D Molecular Therapeutics, Inc. from 2023 to 2025.
Education includes undergraduate studies at Birla Institute of Technology & Science, an MBA from International Institute for Management Development, and graduate studies at Jamnalal Bajaj Institute of Management Studies.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
0%
20-04-2026 1.458 ( 0% ) 11 110 $ 30-06-2026

Eerdere bekende functies van Uneek Mehra

BedrijvenFunctieEinde
4D MOLECULAR THERAPEUTICS, INC. Financieel Directeur/CFO 15-07-2025
NOVARTIS AG Corporate Officer/Principal -
Financieel Directeur/CFO -
Financieel Directeur/CFO -
Ervaring van Uneek Mehra in detail bekijken

Opleiding van Uneek Mehra

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

2

Eerstegraads connecties

9

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit9

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Uneek Mehra